Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Cerilliant
Citi
Dow
Daiichi Sankyo
Johnson and Johnson
Farmers Insurance
Queensland Health

Generated: April 24, 2018

DrugPatentWatch Database Preview

CORZIDE Drug Profile

« Back to Dashboard

When do Corzide patents expire, and what generic alternatives are available?

Corzide is a drug marketed by King Pharms Llc and is included in one NDA.

The generic ingredient in CORZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
Drug patent expirations by year for CORZIDE
Pharmacology for CORZIDE
Synonyms for CORZIDE
Bendroflumethiazide mixture with nadolol
BENDROFLUMETHIAZIDE; NADOLOL
C17H27NO4.C15H14F3N3O4S2
D153992480
LS-178520
Nadolol and bendroflumethazide
Nadolol and bendroflumethiazide
Nadolol/Bendroflumethiazide
SCHEMBL4066540

US Patents and Regulatory Information for CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 ➤ Sign Up ➤ Sign Up
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Argus Health
US Department of Justice
Chinese Patent Office
Merck
McKesson
Mallinckrodt
Citi
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.